3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
9
Not yet recruiting
5
Unknown
4
Recruiting
3
Withdrawn
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
6
Plasma cell
1
Other hematologic neoplasm
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
514
Leukemia
340
Leukemia, Lymphocytic, Chronic, B-Cell
322
Precursor Cell Lymphoblastic Leukemia-Lymphoma
291
Myelodysplastic Syndromes
234
Lymphoma, Non-Hodgkin
173
Lymphoma
162
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
139
Hematologic Neoplasms
133
Multiple Myeloma
121
Lymphoma, Follicular
120
Lymphoma, Large B-Cell, Diffuse
119
Lymphoma, Mantle-Cell
118
Recurrence
115
Hodgkin Disease
99
Burkitt Lymphoma
99
Lymphoma, B-Cell, Marginal Zone
98
Congenital Abnormalities
78
Leukemia, Myelomonocytic, Chronic
77
Leukemia, Myeloid, Chronic-Phase
68
Neoplasms
67
Myeloproliferative Disorders
66
Lymphoma, Large-Cell, Immunoblastic
64
Blast Crisis
59
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
57
Waldenstrom Macroglobulinemia
53
Primary Myelofibrosis
53
Lymphoma, T-Cell, Cutaneous
52
Leukemia, Myeloid, Accelerated Phase
50
Neoplasms, Plasma Cell
48
Interventions
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Febrile Neutropenia
×
Other hematologic neoplasm
×
Clear all
NCT01222819
2016-04-06
G-CSF
Rabin Medical Center
Phase 4
Terminated
120 enrolled